文献速递肾癌与肾肿瘤

大型经皮冷冻消融队列中肾肿瘤复杂性的综合评估

Comprehensive assessment of renal tumour complexity in a large percutaneous cryoablation cohort.
PubMed 文献 · BJU Int · 2017-04-09

该研究基于前瞻性维护的消融登记库(2003-2015),纳入565例患者共580次手术治疗的618个肾肿瘤,评估R.E.N.A.L.肾肿瘤评分(NS)与并发症、肾功能损害、局部失败及肿瘤特异性死亡(CSM)的关联。结果显示,高NS与肿瘤大小驱动的术后并发症风险增加独立相关,NS每增加1分与肾小球滤过率(GFR)额外下降1.3%相关,而局部失败和CSM风险低且与肿瘤复杂性无关。

要点

  • NS每增加1分,并发症风险独立增加(OR 1.3,95%CI 1.2-1.5)。
  • 肿瘤大小是与并发症风险关联最强的NS组分(OR 3.4,95%CI 2.2-5.2)。
  • NS每增加1分,GFR较基线额外下降1.3%(95%CI 0.4-2.1)。

核心结论

  • 在高复杂性肿瘤中,经皮冷冻消融与肿瘤大小驱动的术后并发症风险增加相关。
  • 较高的NS与小幅、临床轻微的额外肾功能下降相关。
  • 无论肿瘤复杂性如何,局部失败和CSM风险均低。

研究设计与样本

  • 利用前瞻性维护的消融登记库(2003-2015)识别接受经皮冷冻消融的肾肿瘤患者。
  • 排除补救性手术和遗传性肿瘤综合征。
  • 共纳入565例患者的618个肿瘤,期间实施580次手术。
  • 采用单变量和多变量逻辑回归、线性回归及Cox回归模型评估NS与并发症、肾功能损害、局部失败及CSM的关联。

主要发现

  • 中位(四分位距[IQR])随访时间为34(14.66)个月。
  • 手术期间任何级别并发症共87例(15%),NS 4-6分组为10%,NS 7-9分组为14%,NS 10-12分组为36%(P < 0.001)。
  • NS每增加1分,并发症风险独立相关(OR 1.3;95%CI 1.2-1.5;P < 0.001)。
  • 肿瘤大小是与并发症风险关联最强的NS组分(OR 3.4;95%CI 2.2-5.2;P < 0.001)。
  • 末次随访时GFR较基线中位(IQR)下降9%(0,22);NS每增加1分,GFR较基线额外下降1.3%(95%CI 0.4-2.1;P = 0.005)。

关键数值与推荐

  • 局部失败共14例(2%),NS 4-6分组为2%,NS 7-9分组为3%,NS 10-12分组为5%(P = 0.32)。
  • CSM共8例(2%),NS 4-6分组为2%,NS 7-9分组为3%,NS 10-12分组为2%(P = 0.88)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between renal tumour complexity and outcomes in a large cohort of patients undergoing percutaneous cryoablation (PCA). PATIENTS AND METHODS: Patients with renal tumours treated with PCA were identified using our prospectively maintained ablation registry (2003-2015). Salvage procedures and inherited tumour syndromes were excluded. The associations between R.E.N.A.L. nephrometry score (NS) and risk of complications, renal function impairment, local failure and cancer-specific mortality (CSM) were evaluated using univariate and multivariable logistic, linear and Cox regression models. RESULTS: The cohort included 618 tumours treated during 580 procedures in 565 patients. The median (interquartile range [IQR]) follow-up was 34 (14.66) months. Complications (any grade) during a procedure (n[total] = 87, 15%) were more frequent with higher NS (NS 4-6: 10%; NS 7-9: 14%; NS 10-12: 36%; P < 0.001). Higher NS was independently associated with risk of complications (odds ratio [OR; per 1 point] = 1.3; 95% confidence interval [CI] 1.2-1.5; P < 0.001). Of all the NS components, tumour size was the most strongly associated with complication risk (OR 3.4; 95% CI 2.2-5.2; P < 0.001). The median (IQR) decline in glomerular filtration rate (GFR) from baseline was 9% (0, 22) at last follow-up. Each additional point in NS was associated with a 1.3% (95% CI 0.4-2.1; P = 0.005) greater GFR decline from baseline. NS was not significantly associated with local failure (n [total] = 14, 2%; NS 4-6: 2%; NS 7-9: 3%; NS 10-12: 5%; P = 0.32) or CSM (n [total] = 8, 2%; NS 4-6: 2%; NS 7-9: 3%; NS 10-12: 2%; P = 0.88). CONCLUSION: In high-complexity tumours PCA was associated with a tumour size-driven increased risk of post-procedural complications. Higher NS was associated with a small, clinically minor additional decline in renal function. Risks for local failure and CSM were low, regardless of tumour complexity.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Bhindi B, Thompson RH, Mason RJ, et al. Comprehensive assessment of renal tumour complexity in a large percutaneous cryoablation cohort. BJU Int. 2017. PMID: 28296030. doi:10.1111/bju.13841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。